ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure

ClinicalTrials.gov ID: NCT06635135

Public ClinicalTrials.gov record NCT06635135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia

Study identification

NCT ID
NCT06635135
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
47 participants

Conditions and interventions

Interventions

  • Aticaprant Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 18, 2024
Primary completion
Apr 8, 2025
Completion
Apr 24, 2025
Last update posted
Mar 11, 2026

2024 – 2025

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Preferred Research Partners Little Rock Arkansas 72211
Wake Research PRI Encino Encino California 91316
Wr Pri Llc Newport Beach California 92660
ATP Clinical Research Orange California 92866
Myndful Research Redlands California 92373
Artemis Institute for Clinical Research San Diego California 92103
UHC Research Doral Florida 33178
Pharmax Research Clinic Inc Miami Florida 33126
GTL Medical and Research Group Miami Florida 33173
International Research Associates, LLC Miami Florida 33183
Harmony Clinical Research Inc North Miami Beach Florida 33162
APG Research LLC Orlando Florida 32803
Interventional Psychiatry of Tampa Bay Tampa Florida 33629
Synexus Clinical Research US Inc Atlanta Georgia 30328
Chicago Research Center Chicago Illinois 60634
Psychiatric Medicine Associates LLC Skokie Illinois 60076
Continental Clinical Solutions Towson Maryland 21204
Massachusetts General Hospital Boston Massachusetts 02114
University of Missouri Health Care Columbia Missouri 65212
IMA Clinical Research PC Albuquerque New Mexico 87109
Integrative Clinical Trials LLC Brooklyn New York 11229
Bioscience Research LLC Mount Kisco New York 10549
Patient Priority Clinical Sites LLC Cincinnati Ohio 45215
Insight Clinical Trials Independence Ohio 44131
Laureate Institute for Brain Research Tulsa Oklahoma 74136
Keystone Clinical Studies LLC Plymouth Meeting Pennsylvania 19462
Coastal Carolina Research Center North Charleston South Carolina 29405
InSite Clinical Research LLC DeSoto Texas 75115
Earle Research Friendswood Texas 77546
Alpine Research Organization Clinton Utah 84015
Elligo Integrated Research Sites Integrated Clinical Research LLC Integrated Psych St. George Utah 84770

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06635135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06635135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →